Drug Utilization and Medical Cost Study Focusing on Moisturizers in Cancer Patients Treated with Molecular Targeted Therapy: A Retrospective Observational Study Using Data from a Japanese Claims Database-Reference-Cited by-同舟云学术

Drug Utilization and Medical Cost Study Focusing on Moisturizers in Cancer Patients Treated with Molecular Targeted Therapy: A Retrospective Observational Study Using Data from a Japanese Claims Database

Published:2022-04 Issue:4 Volume:12 Page:1041-1054
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Kiyohara Yoshio,Matsuzaki Toshiya,Teng Lida,Kishida Momoyo,Kanakubo Akira^ORCID,Motrunich Anastasiia,Onishi Yoshie,Igarashi Ataru

Funder

Maruho Co., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-022-00712-2.pdf

Reference14 articles.

1. Lacouture ME, Anadkat MJ, Bensadoun RJ, et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011;19:1079–95.

2. National Cancer Center Japan, ed. 2016 Clinical guide of appearance care for people receiving cancer treatment [in Japanese]. Tokyo, Kanehara & Co., Ltd; 2016

3. Grande R, Narducci F, Bianchetti S, et al. Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study. Support Care Cancer. 2013;21:1691–5.

4. Watanabe S, Nakamura M, Takahashi H, et al. Dermopathy associated with cetuximab and panitumumab: investigation of the usefulness of moisturizers in its management. Clin Cosmet Investig Dermatol. 2017;11:353–61.

5. Sekiguchi K, Ogita M, Akahane K, et al. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery. Jpn J Clin Oncol. 2015;45:1146–53.